ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Intestinal Microbiome
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1652186
This article is part of the Research TopicCan Chinese Medicines Affect Diarrhea via Effects of the Intestinal Microbiota on the Renal-Intestinal Axis? Volume IIView all 3 articles
Wuling Powder Ameliorates Diarrhea-Predominant Irritable Bowel Syndrome in Mice by Modulating Gut Mucosal Microbiota and Alleviating Intestinal Inflammation
Provisionally accepted
- School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objectives: Wuling powder has been widely used for the clinical treatment of IBS-D, but the microecological mechanism has not been found. This study aimed to investigate the regulatory effect of Wuling powder on intestinal mucosal microbiota in mice with diarrhea predominant-irritable bowel syndrome (IBS-D) by 16S rRNA high-throughput sequencing. Methods: Mice were randomly divided into normal control group (Mc), model control group (Mm), and treatment group (Mt). The IBS-D model was induced via Folium sennae gavage and acute restraint stress, and treatment was conducted with Wuling powder. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and milk fat globule EGF factor 8 (MFGE8) were quantified via enzyme-linked immunosorbent assay (ELISA). Intestinal mucosal DNA was extracted for 16S rRNA gene high-throughput sequencing to analyze microbial community alterations. We analyzed the characteristics of the intestinal mucosal microbiota and explored the potential link between the intestinal mucosal microbiota and the inflammatory response. Results: Compared with the Mc group, the Mm group presented markedly elevated serum TNF-α and IL-6 concentrations (p<0.001; p<0.001) and significantly decreased MFGE8 levels (p<0.01). In contrast, the Mt group presented significant reductions in TNF-α and IL-6 (p<0.05; p<0.05) and a pronounced increase in MFGE8 (p<0.01) relative to those in the Mm group. After treatment with Wuling powder, the abundance and diversity of the intestinal mucosal microbiota were restored. The characteristic genus Sporosarcina was significantly positively correlated with MFGE8, and Paludibaculum was significantly negatively correlated with TNF-α and IL-6. Conclusion: Wuling powder may inhibit the occurrence of an inflammatory response by reducing the TNF-α and IL-6 levels and increasing the MFGE8 level and may achieve the effect of treating IBS-D by regulating the composition, structure, and function of the intestinal mucosal microbiota, which provides new ideas for the clinical prevention and treatment of IBS-D via Wuling powder.
Keywords: Wuling Powder, Diarrhea Predominant-Irritable Bowel Syndrome, Intestinal mucosal microbiota, 16S rRNA, TCM, Inflammation
Received: 23 Jun 2025; Accepted: 22 Jul 2025.
Copyright: © 2025 Tian, Yu, Shen, Fang and Cai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ying Cai, School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.